Author:
Chavez Antonio Romo de Vivar,Buchser William,Basse Per H.,Liang Xiaoyan,Appleman Leonard J.,Maranchie Jodi K.,Zeh Herbert,De Vera Michael E.,Lotze Michael T.
Subject
History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Reference56 articles.
1. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2;Rosenberg;JAMA,1994
2. A phase III multi-institutional randomized study of immunization with the gp100: 209-217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma;Schwartzentruber;J. Clin. Onc.,2009
3. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2;Lotze;J. Immunol.,1985
4. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2;Lotze;J. Immunol.,1985
5. Systemic administration of interleukin-2 in humans;Lotze;J. Biol. Response Mod.,1984
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献